Abstract
Introduction
The handling of the chromatography equipment seems complex to the analysts or researchers who have not encountered with it before but once they came to know the mechanism of its parts and its procedure they feel like it's a simple machine to handle. parts namely pump, detectors and injectors with different combinations yields a no of components based on its applications. Analyst should understand the vital role of each part like an an understanding of human anatomy towards your wellbeing and vitality with a knowledge on role of each organ. Once an analyst is familiar with the parts and its role it is easy to generate a data of highest reliability. An understanding of the function of each component on a conceptual basis will make you feel comfortable while handling HPLC system. The present module is intended to serve this very purpose and in simple terms you will appreciate the role of each part and its contribution to overall system efficiency. HPLC is a technique for separation, identification and quantification of components in a mixture. It is especially suitable for compounds with high molecular weights, thermally unstable and which are not easily volatilized can be separated, identified through HPLC technique [1] .
Selectivity of HPLC-Method Development
HPLC method is used to analyze most of the drugs because of several advantages of this method like specific, accurate, precise, rapid, automatic and eliminates tedious extraction and isolation procedures [2] . Advantages are as follows: 
Parameters recommendations
1. Theoretical plates (N) = >2000 2. Tailing factor (T) = ≤ 2 3. Resolution (Rs) = >2 between peak of interest and the closest Eluting potential interference 4. Repeatability = RSD ≤ 2% 5. Capacity factor (k1) = >2.0
Method validation
Method validation is the process by which it is established, through laboratory studies, that the performance characteristics of the method meet the requirements for its intended purpose [3] [4] [5] . It is a part of the overall validation process that also includes software validation, instrument qualification and system suitability. Typical analytical characteristics used in method validation are highlighted below. Although all analytical procedures or methods used in a regulated laboratory must be validated, this chart focuses specifically on liquid chromatography. Typical analytical characteristics used in method validation, commonly referred to as the "Eight steps of method of validation". Mechanism of action: It shoes its mechanism of action by producing a bronchodilatory effect through its selective action on M3 muscarinic receptors located in the airways. Tiotropium is also referred to as an antimuscarinic or anticholinergic agent.
Indication: Used in the management of chronic obstructive pulmonary disease (COPD).
Olodaterol
Description: Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA)
Category: Drugs for Obstructive Airway Diseases Respiratory System
Structure:
IUPAC Name:
Chemical formula: C21H26N2O5 Molecular weight: 386.448
Mechanism of action:
Olodaterol is a long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-drenergic receptors located primarily in the lungs. Beta2-adrenergic receptors are membrane-bound receptors that are normally activated by endogenous epinephrine whose signalling, via a downstream L-type calcium channel interaction, mediates smooth muscle relaxation and bronchodilation. Activation of the receptor stimulates an associated G protein which then activates adenylate cyclase, catalysing the formation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). Elevation of these two molecules induces bronchodilation by relaxation of airway smooth muscles.
Indication:
Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), for the treatment of asthma.
Methods and Materials
The efficiency was more than 2000 Olodaterol and Tiotropium Bromide. Resolution between two peaks >1.5 [8] [9] [10] [11] .
Method development trials
Trial-1 Observation: Although the Efficiency was not satisfactory for Olodaterol. The peak response of Tiotropium Bromide was very less.
Trial-2
Observation: Efficiency of both the drugs was good. The run time is very more. The Peaks of Tiotropium Bromide and Olodaterol showed tailing.
Trial-3
Observation: Asymmetry factor for Olodaterol does not meet the system suitability requirements. The run time is 11 minutes.
Trial-4
Observation: Peak Asymmetry factor for Tiotropium Bromide and Diloxanide fuorate does not meet the system suitability requirements. The run time is very more.
Trial-5
Observation: All the system suitability requirements were met. The peak Asymmetry factor was less than 2 for both Olodaterol and Tiotropium Bromide (Table 1) .
Optimized chromatographic conditions
• Mobile phase=Triethylamine buffer+CAN Bromide and 50 μg/ml of Olodaterol is prepared by diluting 1 ml to 10 ml with mobile phase. This solution is used for recording chromatogram.
Calculation
The amount of Olodaterol and Tiotropium Bromide present in the Formulation by using the formula given below, and results shown in above table % Assay = AT × WS × DT × P × AW × 100
AS × DS × WT × 100 × LC Where, AS: Average peak area due to standard preparation AT: Peak area due to assay preparation WS: Weight of Olodaterol/Tiotropium Bromide in mg WT: Weight of sample in assay preparation DT: Dilution of assay preparation
Observation
The amount of Tiotropium Bromide and Olodaterol present in the taken dosage form was found to be 99.8% and 99.6% respectively ( Table 2) .
Validation Parameters
System suitability Standard solutions were prepared as per the test method and injected into the chromatographic system [12] [13] [14] . The system suitability parameters like theoretical plates, resolution and asymmetric factor were evaluated (Tables  3 and 4) .
Acceptance criteria
1. The % RSD for the retention times of Tiotropium Bromide and Olodaterol Peaks from 6 replicate injections of each Standard solution should be not more than 2.0% 2. The % RSD for the peak area responses of Tiotropium Bromide and Lumacaftor peaks from 6 replicate injections of each standard solution should be not more than 2.0%. 3. The number of theoretical plates (N) for the Tiotropium Bromide and Olodaterol peaks is not less than 2000.
The Tailing factor (T) for the Tiotropium Bromide
and Olodaterol peak is not more than 2.0.
Observation
The % RSD for the retention times and peak area of Tiotropium Bromide and Olodaterol were found to be less than 2%. The plate count and tailing factor results were found to be satisfactory and are found to be within the limit. 
Linearity and range

Preparation of standard stock solution
Standard stock solutions of Tiotropium Bromide and Olodaterol (mg/ml) were prepared by dissolving 60 mg of Tiotropium Bromide and 50 mg of Olodaterol dissolved in sufficient mobile phase and dilute to 100 ml with mobile phase (Tables 5 and 6 ) [13] [14] [15] [16] [17] [18] [19] [20] .
Acceptance criteria
The relationship between the concentration of Tiotropium Bromide and Olodaterol and area of Tiotropium Bromide and Olodaterol should be linear in the specified range and the correlation should not be less than 0.99.
Observation
The correlation coefficient for linear curve obtained between concentration vs. Area for standard preparations of Tiotropium Bromide and Lumacaftor is 0.998 and 0.997. The relationship between the concentration of Tiotropium Bromide and Olodaterol and area of Tiotropium Bromide and Olodaterol is linear in the range examined since all points lie in a straight line and the correlation coefficient is well within limits (Figures 1 and 2 ). 
Accuracy
Accuracy of the method was determined by Recovery studies. To the formulation (pre analyzed sample), the reference standards of the drugs were added at the level of 50%, 100%, 150%. The recovery studies were carried out three times and the percentage recovery and percentage mean recovery were calculated for drug is shown in table. Recovery studies were carried out at three different levels 50%, 100%, 150% by addition of standard drug solution to pre-analyzed sample solution to check the accuracy of the method (Tables 7 and 8 ).
Acceptance criteria
The % recovery of Tiotropium Bromide and Olodaterol should lie between 98% and 102%.
Observation
The % mean recovery of Tiotropium Bromide and Olodaterol is 100.93% and108.93% respectively.
Precision
Method precision
Prepared sample preparations of Olodaterol and Tiotropium Bromide as per test method and injected 6 times in to the column (Tables 9 and 10 ).
Acceptance criteria
The % RSD of Assay preparations of Olodaterol and Tiotropium Bromide should be not more than 2.0%.
Observation
Test results for Olodaterol and Tiotropium Bromide are showing that the % RSD of Assay results are within limits. Where, σ = the standard deviation of the response S = the slope of the calibration curve
Limit of detection
The slope S may be estimated from the calibration curve of the analyte.
Observation
The LOD for this method was found to be 0.0862 μg/ml and 0.0424 μg/ml for Olodaterol.
Limit of quantification
LOQ=10σS
= (10) 
Robustness
Chromatographic conditions variation
To demonstrate the robustness of the method, prepared solution as per test method and injected at different variable conditions like using different conditions like flow rate and wavelength. System suitability parameters were compared with that of method precision (Table  11) .
Acceptance criteria
The system suitability should pass as per the test method at variable conditions.
Observation
From the observation it was found that the system suitability parameters were within limit at all variable conditions.
Ruggedness
The ruggedness of the method was studied by the determining the analyst to analyst variation by performing the Assay by two different analysts (Table  12) .
Acceptance criteria
The % Relative standard deviation of Assay values between two analysts should be not more than 2.0%.
Observation
From the observation the between two analysts Assay values not greater than 2.0%, hence the method was rugged. 
Conclusion
From the above experimental results and parameters, it was concluded that, this newly developed method for the simultaneous estimation Tiotropium Bromide and Olodaterol was found to be simple, precise, accurate and high resolution and shorter retention time makes this method more acceptable and cost effective and it can be effectively applied for routine analysis in research institutions, quality control department in meant in industries, approved testing laboratories studies in near future.
